Trials / Terminated
TerminatedNCT00708357
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- Male
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
Nitric oxide (NO) is a potent endothelium-derived vasodilatator that plays a major role in the control of ocular blood flow. Endothelial NO synthase (eNOS) is one of three isoforms of NOS producing NO through hydroxylation of L-arginine. The eNOS gene is located on the long arm of chromosome 7, and different polymorphic variations have been identified. These single nucleotide polymorphisms (sNP´s) have the ability to change transcription activity and therefore enzyme levels. Recent data indicate that the T -786C polymorphism (especially the homozygous variant) is associated with reduced eNOS activity and consequently impaired NO production. In the present study the investigators want to investigate if the T -786C eNOS gene polymorphism determines choroidal and optic nerve head blood flow.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NG-monomethyl-L-arginine | intravenous administration, bolus over 5 minutes, dosage 6mg/kg |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2009-12-01
- Completion
- 2013-01-01
- First posted
- 2008-07-02
- Last updated
- 2014-11-17
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00708357. Inclusion in this directory is not an endorsement.